Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy

Diagnosis and Management of Hypertrophic Cardiomyopathy

Volumn , Issue , 2007, Pages 67-80

  Hagège, Albert A ^a   Schwartz, Ketty ^b   Desnos, Michel ^a   Carrier, Lucie ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiac troponin; Contractile proteins; Genotype phenotype relationships; Morbid genes; Mutations

Indexed keywords

EID: 33444470457     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987469.ch3     Document Type: Chapter

References (76)

1. Jarcho JA, McKenna W, Pare JAP et al. Mapping a gene for familial hypertrophic cardio-myopathy to chromosome 14ql. N Engl J Med 1989; 321: 1372-8.
2. Watkins H, MacRae C, Thierfelder L et al. A disease locus for familial hypertrophic car-diomyopathy maps to chromosome 1q3. Nat Genet 1993; 3: 333-7.
3. Thierfelder L, MacRae C, Watkins H et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 1993; 90: 6270-4.
4. Carrier L, Hengstenberg C, Beckmann JS et al. Mapping of a novel gene for familial hy-pertrophic cardiomyopathy to chromosome 11. Nat Genet 1993; 4: 311-13.
5. Geisterfer-Lowrance AAT, Kass S, Tanigawa G et al. A molecular basis for familial hyper-trophic cardiomyopathy: A P cardiac myosin heavy chain gene missense mutation. Cell 1990; 62: 999-1006.
6. Thierfelder L, Watkins H, MacRae C et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994; 77: 701-12.
7. Bonne G, Carrier L, Bercovici J et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995; 11: 438-40.
8. Watkins H, Conner D, Thierfelder L et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995; 11: 434-7.
9. Bonne G, Carrier L, Richard P et al. Familial hypertrophic cardiomyopathy: From mutations to functional defects. Circ Res 1998; 83: 579-593.
10. Seidman JG, Seidman CE. The genetic basis for cardiomyopathy: From mutation identifi-cation to mechanistic paradigms. Cell 2001; 104: 557-67.
11. Poetter K, Jiang H, Hassanzadeh S et al. Mutation in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996; 13: 63-9.
12. Flavigny J, Richard P, Isnard R et al. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med 1998; 76: 208-14.
13. Mogensen J, Klausen IC, Pedersen AK et al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 1999; 103: R39-R43.
14. Kimura A, Harada H, Park JE et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379-82.
15. Satoh M, Takahashi M, Sakamoto T et al. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Biochem Biophys Res Commun 1999; 262: 411-17.
16. Hoffmann B, Schmidt-Traub H, Perrot A et al. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 2001; 17: 524.
17. Patton KK, Niimura H, Soults J et al. Sarcomere protein gene mutations: A frequent cause of elderly-onset hypertrophic cardiomyopathy. Circulation 2000; 102 (Suppl. II): 178.
18. Blair E, Redwood C, Ashrafian H et al. Mutations in the y2-subunit of AMP-activated pro-tein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001; 10: 1215-20.
19. Gollob MH, Green MS, Tang ASL et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001; 344: 1823-64.
20. Fung DC, Yu B, Littlejohn T et al. An online locus-specific mutation database for familial hypertrophic cardiomyopathy. Hum Mutat 1999; 14: 326-32.
21. Nishi H, Kimura A, Harada H et al. Possible gene dose effect of a mutant cardiac P-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1994; 200: 549-56.
22. Jeschke B, Uhl K, Weist B et al. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated P-myosin heavy chain genes. Hum Genet 1998; 102: 299-304.
23. Richard P, Isnard R, Carrier L et al. Double heterozygosity for mutations in the beta myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 1999; 36: 542-5.
24. Richard P, Charron P, Leclercq C et al. Homozygotes for a R869G mutation in the beta-myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32: 1575-83.
25. Ho CY, Lever HM, DeSanctis R et al. Homozygous mutation in cardiac troponin T. Impli-cations for hypertrophic cardiomyopathy. Circulation 2000; 102: 1950-5.
26. Forissier J-F, Richard P, Briault S et al. First description of a germ line mosaicism in familial hypertrophic cardiomyopathy. J Med Genet 2000; 37: 132-4.
27. Regitz-Zagrosek V, Erdmann J, Wellnhofer E et al. Novel mutation in the a-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Cir-culation 2000; 102: e112-6.
28. Olson TM, Michels VV, Thibodeau SN et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280: 750-2.
29. Kamisago M, Sharma SD, DePalma SR et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343: 1688-96.
30. Cuda G, Fananapazir L, Zhu WS et al. Skeletal muscle expression and abnormal function of P-myosin in hypertrophic cardiomyopathy. J Clin Invest 1993; 91: 2861-5.
31. Bottinelli R, Coviello DA, Redwood CS et al. A mutant tropomyosin that causes hyper-trophic cardiomyopathy is expressed in vivo and associated with increased calcium sensitivity. Circ Res 1998; 82: 106-15.
32. Rottbauer W, Gautel M, Zehelein J et al. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest 1997; 100: 475-82.
33. Moolman JA, Reith S, Uhl K et al. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation 2000; 101: 1396-402.
34. Yang Q, Sanbe A, Osinska H et al. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest 1998; 102: 1292-300.
35. Flavigny J, Souchet M, Sébillon P et al. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol 1999; 294: 443-56.
36. Yang Q, Sanbe A, Osinska H et al. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Circ Res 1999; 85: 841-7.
37. McConnell BK, Fatkin D, Semsarian C et al. Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res 2001; 88: 383-9.
38. Sebillon P, Bonne G, Flavigny J et al. COOH-terminal truncated human cardiac MyBP-C alters myosin filament organization. C R Acad Sci 2001; 324: 251-60.
39. Charron P, Dubourg O, Desnos M et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997; 96: 214-19.
40. Ko YL, Chen JJ, Tang TK et al. Malignant familial hypertrophic cardiomyopathy in a family with a Arg453Cys mutation in the P-myosin heavy chain gene: Coexistence of sudden death and end-stage heart failure. Hum Gen 1996; 97: 585-90.
41. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic car-diomyopathy: Insights provided by comparisons of kindreds with distinct and identical P-myosin heavy chain gene mutations. Circulation 1994; 89: 22-32.
42. Abchee A, Marian AJ. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J Invest Med 1997; 45: 191-6.
43. Tesson F, Richard P, Charron P et al. Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardio-myopathy. Hum Mutat 1998; 12: 385-92.
44. Charron P, Dubourg O, Desnos M et al. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein C and the P-myosin heavy chain genes. Eur Heart J 1998; 19: 139-45.
45. Gruver EJ, Fatkin D, Dodds GA et al. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His P-cardiac myosin heavy chain mutation. Am J Cardiol 1999; 83 (12A): 13H-18H.
46. Epstein ND, Cohn GM, Cyran F et al. Difference in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the P-myosin heavy chain gene: A Leu908Val mutation and an Arg403Gly mutation. Circulation 1992; 86: 345-52.
47. Watkins H, McKenna WJ, Thierfelder L et al. Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332: 1058-64.
48. Marian AJ, Mares A Jr, Kelly DP et al. Sudden cardiac death in familial hypertrophic car-diomyopathy. Variability in phenotypic expression of P-myosin heavy chain mutations. Eur Heart J 1995; 16: 368-76.
49. Havndrup O, Bundgaard H, Andersen PS et al. The Val606Met mutation in the cardiac P-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age. Am J Cardiol 2001; 87: 1315-17.
50. Semsarian C, Yu B, Ryce C, Lawrence C et al. Sudden cardiac death in familial hypertrophic cardiomyopathy: Are 'benign' mutations really benign? Pathology 1997; 29: 305-8.
51. Charron P, Dubourg O, Desnos M et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998; 97: 2230-6.
52. Erdmann J, Raible J, Maki-Abadi J et al. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol 2001; 38: 322-30.
53. Moolman JC, Corfield VA, Posen B et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997; 29: 549-55.
54. Varnava A, Baboonian C, Davison F et al. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 1999; 82: 621-4.
55. Anan R, Shono H, Kisanuki A et al. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 1998; 98: 391-7.
56. Kokado H, Shimizu M, Yoshio H et al. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.Circulation 2000; 102: 663-9.
57. Karibe A, Tobacman LS, Strand J et al. Hypertrophic cardiomyopathy caused by a novel a-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling and poor prognosis. Circulation 2001; 103: 65-71.
58. Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H et al. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the a-tropomyosin gene. Heart 1996; 76: 63-5.
59. Coviello DA, Maron BJ, Spirito P et al. Clinical features of hypertrophic cardiomyopathy caused by mutation of a 'hot spot' in the a-tropomyosin gene. J Am Coll Cardiol 1997; 29: 635-40.
60. Mogensen J, Klausen IC, Pedersen AK et al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 1999; 103: R39-43.
61. Lee W, Hwang TH, Kimura A et al. Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy. Am Heart J 2001; 141: 184-9.
62. Hagege AA, Dubourg O, Desnos M et al. Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. Eur Heart J 1998; 19: 490-9.
63. Niimura H, Bachinski LL, Sangwatanaroj S et al. Mutations in the gene for human cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998; 338: 1248-57.
64. Maron BJ, Niimura H, Casey SA et al. Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001; 38: 315-21.
65. Lin T, Ichihara S, Yamada Y et al. Phenotypic variation of familial hypertrophic cardio-myopathy caused by the Phe(110)Ile mutation in cardiac troponin T. Cardiology 2000; 93: 155-62.
66. Marian AJ, Yu Q-T, Workman R et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342: 1085-6.
67. Lechin M, Quinones MA, Omran A et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92: 1802-12.
68. Yonega K, Okamoto H, Machida M et al. Angiotensin-converting enzyme gene polymor-phism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1995; 130: 1089-93.
69. Tesson F, Dufour C, Moolman JC et al. The influence of the angiotensin I converting en-zyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 1997; 29: 831-8.
70. Brugada R, Kelsey W, Lechin M et al. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Investig Med 1997; 45: 542-51.
71. Patel R, Lim DS, Reddy D et al. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32: 2369-677.
72. Charron P, Carrier L, Dubourg O et al. Penetrance of familial hypertrophic cardiomyopa-thy. Genet Couns 1997; 8: 107-14.
73. Vikstrom KL, Factor SM, Leinwand LA. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med 1996; 2: 556-67.
74. Ackerman MJ, VanDriest SL, Ommen SR et al. Prevalence and age-dependence of ma-lignant mutations in the beta-myosin heavy chain and troponin T gene in hypertrophic cardiomyopathy: A comprehensive outstanding perspective. J Am Coll Cardiol 2002; 39: 2049-51.
75. Van Driest BA, Ackerman MJ, Ommen SR et al. Prevalence and severity of 'benign' mu-tations in the ß-myosin heavy chain, cardiac troponin T and a-tropomyosin genes in hypertrophic cardiomyopathy. Circulation 2002; 106: 3085.
76. Geier C, Perrot A, Özcelik C et al. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 2003; 107: 1390-5.